• No notifications yet.
  • Sign Out
logo image
  • logo image
Registered User? Login

The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only. 

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Forgot Password?
Sign Up
loader image
New User? Sign Up

The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only. 

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Forgot Password?
Login
loader image

    Why Attend?

    Full Overview

    Chronic obstructive pulmonary disease (COPD) has risen to become the third leading cause of death worldwide and is underfunded, under-prioritised and undertreated. Despite its prevalence and considerable cost to healthcare systems, COPD is relatively unknown by both the public and policymakers. A lack of understanding, misperceptions and negative bias surrounding COPD impacts timely and quality care for people with the disease. More severe COPD, meanwhile, is associated with higher healthcare utilisation, placing strains on already overstretched healthcare budgets. Better ways are urgently needed to address the significant burden that COPD places on both patients, carers and society.

    The COVID-19 pandemic has put respiratory care in the spotlight and highlighted gaps that need urgent attention. With world policymakers now focused health and respiratory diseases, there is an opportunity to push for higher prioritisation and reform in the broader respiratory disease space. Policy change in the way we prevent, diagnose, and treat COPD care could play a considerable role on the recovery of healthcare systems post-pandemic, making them more sustainable and more resilient to future challenges.

    Recognising the significant economic and social benefits that can accrue, some governments are making progress in promoting COPD and other respiratory diseases as priorities in their health systems’ long term care plans, but much more needs to be done. Meanwhile, many real-word examples are emerging of policy and practice that can improve outcomes for people with the disease.

    The Financial Times, in partnership with AstraZeneca is honoured to host this exclusive virtual webinar for stakeholders in the global respiratory community and for those impacted by or engaged in the care of patients with COPD. Join an esteemed panel of health policymakers, leading clinicians and patient representatives as they discuss the path forward for improving respiratory strategies across governments, with sustainable and measurable impacts for patients.

    register for free

    Premier Digital Events supported by the world's best journalism

    Using leading digital technology, we have now taken our content, global audience reach and engagement to a new level through a series of unmissable virtual events. Our compelling events are chaired by respected FT journalists, feature the most senior and thought-provoking decision-makers in business, finance and politics, all accessible from your office or home.

    View all events

    Z4-39027 | October 2021 

    © Financial Times Live

    FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice

                    

    LEGAL

    FT Live Website Terms of Use
    Slavery Statement & Policies
    Contact us



    FT Live Delegate Terms & Conditions
    Privacy policy
    Cookie policy

Contact the organizer
Contact the organizer